pmod version 4.4 (PMOD Technologies)
90
Structured Review
PMOD Technologies
pmod version 4.4
Pmod Version 4.4, supplied by PMOD Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pmod+version+4%2E4/pmod+version+3+7/pm40591182-106-8-11
Average 90 stars, based on 1 article reviews
Pmod Version 4.4, supplied by PMOD Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pmod+version+4%2E4/pmod+version+3+7/pm40591182-106-8-11
Average 90 stars, based on 1 article reviews
pmod version 4.4 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Positron Emission Tomography:Article Title: The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature. Article Snippet: Portal hypertension (PH) can cause severe complications in patients with advanced chronic liver disease (aCLD).. The pan-peroxisome proliferator-activated receptor (pan-PPAR) agonist lanifibranor reduces portal pressure in preclinical models of aCLD.. Since the effect on PH might be secondary to fibrosis improvement, we investigated the effect of lanifibranor on PH, hepatic and splanchnic angiogenesis in mouse models of fibrotic and prehepatic non-fibrotic PH. Article Title: Characterization of in vivo binding kinetics and non-displaceable binding of [ 18 F]SynvesT-1 in the rat brain. Article Snippet: The parent fraction curve was fitted with the Watabe model as implemented in Article Title: A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements Article Snippet: PET/CT image analysis was performed using Article Title: Image analysis: 68 Ga-FAPI-46 PET derived texture parameters improve the differentiation of malignant and benign pulmonary lesions. Article Snippet: Lesion segmentation and feature extraction was performed using Article Title: Preclinical validation of a novel brain-penetrant PET ligand for visualization of histone deacetylase 6: a potential imaging target for neurodegenerative diseases. Article Snippet: Purpose Histone deacetylase 6 (HDAC6) has emerged as a therapeutic target for neurodegenerative diseases such as Alzheimer’s disease.. Noninvasive imaging of HDAC6 in the brain by positron emission tomography (PET) would accelerate research into its roles in these diseases.. We recently discovered an 18F-labeled derivative of the selective HDAC6 inhibitor SW-100 ([18F]FSW-100) as a potential candidate for brain HDAC6 radioligand. Article Title: A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements Article Snippet: SPECT/CT image analysis was performed using Article Title: Assessing PET performance, image quality, and attenuation correction in the presence of RF coils within a 9.4 T MRI for preclinical simultaneous imaging. Article Snippet: The software programs AMIDE (version 1.0.4) [14] and Software:Article Title: The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature. Article Snippet: Portal hypertension (PH) can cause severe complications in patients with advanced chronic liver disease (aCLD).. The pan-peroxisome proliferator-activated receptor (pan-PPAR) agonist lanifibranor reduces portal pressure in preclinical models of aCLD.. Since the effect on PH might be secondary to fibrosis improvement, we investigated the effect of lanifibranor on PH, hepatic and splanchnic angiogenesis in mouse models of fibrotic and prehepatic non-fibrotic PH. Article Title: Characterization of in vivo binding kinetics and non-displaceable binding of [ 18 F]SynvesT-1 in the rat brain. Article Snippet: The parent fraction curve was fitted with the Watabe model as implemented in Article Title: A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements Article Snippet: PET/CT image analysis was performed using Article Title: Image analysis: 68 Ga-FAPI-46 PET derived texture parameters improve the differentiation of malignant and benign pulmonary lesions. Article Snippet: Lesion segmentation and feature extraction was performed using Article Title: Preclinical validation of a novel brain-penetrant PET ligand for visualization of histone deacetylase 6: a potential imaging target for neurodegenerative diseases. Article Snippet: Purpose Histone deacetylase 6 (HDAC6) has emerged as a therapeutic target for neurodegenerative diseases such as Alzheimer’s disease.. Noninvasive imaging of HDAC6 in the brain by positron emission tomography (PET) would accelerate research into its roles in these diseases.. We recently discovered an 18F-labeled derivative of the selective HDAC6 inhibitor SW-100 ([18F]FSW-100) as a potential candidate for brain HDAC6 radioligand. Article Title: A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements Article Snippet: SPECT/CT image analysis was performed using Article Title: Assessing PET performance, image quality, and attenuation correction in the presence of RF coils within a 9.4 T MRI for preclinical simultaneous imaging. Article Snippet: The software programs AMIDE (version 1.0.4) [14] and Single Photon Emission Computed Tomography:Article Title: The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature. Article Snippet: Portal hypertension (PH) can cause severe complications in patients with advanced chronic liver disease (aCLD).. The pan-peroxisome proliferator-activated receptor (pan-PPAR) agonist lanifibranor reduces portal pressure in preclinical models of aCLD.. Since the effect on PH might be secondary to fibrosis improvement, we investigated the effect of lanifibranor on PH, hepatic and splanchnic angiogenesis in mouse models of fibrotic and prehepatic non-fibrotic PH. Article Title: Characterization of in vivo binding kinetics and non-displaceable binding of [ 18 F]SynvesT-1 in the rat brain. Article Snippet: The parent fraction curve was fitted with the Watabe model as implemented in Article Title: A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements Article Snippet: PET/CT image analysis was performed using Article Title: Image analysis: 68 Ga-FAPI-46 PET derived texture parameters improve the differentiation of malignant and benign pulmonary lesions. Article Snippet: Lesion segmentation and feature extraction was performed using Article Title: Preclinical validation of a novel brain-penetrant PET ligand for visualization of histone deacetylase 6: a potential imaging target for neurodegenerative diseases. Article Snippet: Purpose Histone deacetylase 6 (HDAC6) has emerged as a therapeutic target for neurodegenerative diseases such as Alzheimer’s disease.. Noninvasive imaging of HDAC6 in the brain by positron emission tomography (PET) would accelerate research into its roles in these diseases.. We recently discovered an 18F-labeled derivative of the selective HDAC6 inhibitor SW-100 ([18F]FSW-100) as a potential candidate for brain HDAC6 radioligand. Article Title: A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements Article Snippet: SPECT/CT image analysis was performed using Article Title: Assessing PET performance, image quality, and attenuation correction in the presence of RF coils within a 9.4 T MRI for preclinical simultaneous imaging. Article Snippet: The software programs AMIDE (version 1.0.4) [14] and Positron Emission Tomography-Computed Tomography:Article Title: The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature. Article Snippet: Portal hypertension (PH) can cause severe complications in patients with advanced chronic liver disease (aCLD).. The pan-peroxisome proliferator-activated receptor (pan-PPAR) agonist lanifibranor reduces portal pressure in preclinical models of aCLD.. Since the effect on PH might be secondary to fibrosis improvement, we investigated the effect of lanifibranor on PH, hepatic and splanchnic angiogenesis in mouse models of fibrotic and prehepatic non-fibrotic PH. Article Title: Characterization of in vivo binding kinetics and non-displaceable binding of [ 18 F]SynvesT-1 in the rat brain. Article Snippet: The parent fraction curve was fitted with the Watabe model as implemented in Article Title: A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements Article Snippet: PET/CT image analysis was performed using Article Title: Image analysis: 68 Ga-FAPI-46 PET derived texture parameters improve the differentiation of malignant and benign pulmonary lesions. Article Snippet: Lesion segmentation and feature extraction was performed using Article Title: Preclinical validation of a novel brain-penetrant PET ligand for visualization of histone deacetylase 6: a potential imaging target for neurodegenerative diseases. Article Snippet: Purpose Histone deacetylase 6 (HDAC6) has emerged as a therapeutic target for neurodegenerative diseases such as Alzheimer’s disease.. Noninvasive imaging of HDAC6 in the brain by positron emission tomography (PET) would accelerate research into its roles in these diseases.. We recently discovered an 18F-labeled derivative of the selective HDAC6 inhibitor SW-100 ([18F]FSW-100) as a potential candidate for brain HDAC6 radioligand. Article Title: A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements Article Snippet: SPECT/CT image analysis was performed using Article Title: Assessing PET performance, image quality, and attenuation correction in the presence of RF coils within a 9.4 T MRI for preclinical simultaneous imaging. Article Snippet: The software programs AMIDE (version 1.0.4) [14] and |